BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21402436)

  • 1. HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies.
    da Silva SR; de Oliveira DE
    Cancer Lett; 2011 Jun; 305(2):175-85. PubMed ID: 21402436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
    Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
    Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB signaling modulation by EBV and KSHV.
    de Oliveira DE; Ballon G; Cesarman E
    Trends Microbiol; 2010 Jun; 18(6):248-57. PubMed ID: 20452220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection.
    Pinzone MR; Berretta M; Cacopardo B; Nunnari G
    Semin Oncol; 2015 Apr; 42(2):258-71. PubMed ID: 25843730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS and associated malignancies.
    Wood C; Harrington W
    Cell Res; 2005; 15(11-12):947-52. PubMed ID: 16354573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of HIV-associated malignancies].
    Launay O; Guillevin L
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G; Barbarini G
    Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.
    Swaminathan S
    Semin Hematol; 2003 Apr; 40(2):107-15. PubMed ID: 12704587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV.
    Taylor GS; Blackbourn DJ
    Cancer Lett; 2011 Jun; 305(2):263-78. PubMed ID: 21470769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-herpesvirus neoplasia: a growing role for COX-2.
    Shelby BD; Nelson A; Morris C
    Microsc Res Tech; 2005 Nov; 68(3-4):120-9. PubMed ID: 16276519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders.
    Dolcetti R; Di Luca D; Carbone A; Mirandola P; De Vita S; Vaccher E; Sighinolfi L; Gloghini A; Tirelli U; Cassai E; Boiocchi M
    J Med Virol; 1996 Apr; 48(4):344-53. PubMed ID: 8699167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.
    Miller G; Rigsby MO; Heston L; Grogan E; Sun R; Metroka C; Levy JA; Gao SJ; Chang Y; Moore P
    N Engl J Med; 1996 May; 334(20):1292-7. PubMed ID: 8609946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Cesarman E; Knowles DM
    Semin Diagn Pathol; 1997 Feb; 14(1):54-66. PubMed ID: 9044510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS-Associated Malignancies.
    Vangipuram R; Tyring SK
    Cancer Treat Res; 2019; 177():1-21. PubMed ID: 30523619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS-related lymphomas: from pathogenesis to pathology.
    Carbone A; Gloghini A
    Br J Haematol; 2005 Sep; 130(5):662-70. PubMed ID: 16115121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy.
    Simonelli C; Tedeschi R; Gloghini A; Bortolin MT; Spina M; Bidoli E; Cinelli R; De Paoli P; Carbone A; Tirelli U
    Clin Infect Dis; 2005 Apr; 40(7):1022-7. PubMed ID: 15824995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.